135 related articles for article (PubMed ID: 37233913)
1. Keeping Safe and Effective Medications Accessible.
Mazer-Amirshahi M; Ye P; Stolbach A
J Med Toxicol; 2023 Jul; 19(3):244-245. PubMed ID: 37233913
[No Abstract] [Full Text] [Related]
2. The approval of mifepristone (RU486) in the United States: What's wrong with this picture?
Blumenthal P; Johnson J; Stewart F
Medscape Womens Health; 2000; 5(4):E7. PubMed ID: 11109052
[No Abstract] [Full Text] [Related]
3. Mifepristone Paternalism at the FDA.
Paradise J
J Law Med Ethics; 2023; 51(3):554-559. PubMed ID: 38088593
[TBL] [Abstract][Full Text] [Related]
4. Mifepristone for termination of early pregnancy.
FDA Consum; 2000; 34(6):7. PubMed ID: 11192820
[No Abstract] [Full Text] [Related]
5. The long, winding road of RU-486.
Check E
Newsweek; 2000 Oct; 136(14):50. PubMed ID: 11183341
[No Abstract] [Full Text] [Related]
6. Mifepristone (Korlym) for Cushing's syndrome.
Med Lett Drugs Ther; 2012 Jun; 54(1392):46-7. PubMed ID: 22683927
[No Abstract] [Full Text] [Related]
7. Time to Reevaluate U.S. Mifepristone Restrictions.
Henney JE; Gayle HD
N Engl J Med; 2019 Aug; 381(7):597-598. PubMed ID: 31242357
[No Abstract] [Full Text] [Related]
8. Judicial interference with mifepristone.
Hamburg M; Sharfstein J
Science; 2023 Apr; 380(6642):223. PubMed ID: 37053463
[TBL] [Abstract][Full Text] [Related]
9. Abortion pill gets FDA approval.
SoRelle R
Circulation; 2000 Oct; 102(15):E9030-1. PubMed ID: 11183868
[No Abstract] [Full Text] [Related]
10. Mifepristone: less obvious adverse effects.
Rudd G
Ann Pharmacother; 2001 Mar; 35(3):381-2. PubMed ID: 11261540
[No Abstract] [Full Text] [Related]
11. A little pill but a big dispute.
Whitman D; Schultz S
US News World Rep; 2000 Oct; 129(14):18-9, 22. PubMed ID: 11183344
[No Abstract] [Full Text] [Related]
12. An introduction to risk evaluation and mitigation strategies.
Dohm J; Ji M
Contraception; 2021 Jul; 104(1):4-7. PubMed ID: 33905706
[No Abstract] [Full Text] [Related]
13. New warning for mifepristone and misoprostol.
Lancet; 2005 Jul 30-Aug 5; 366(9483):344. PubMed ID: 16075477
[No Abstract] [Full Text] [Related]
14. Former FDA chief cites five things to watch for on drug approvals and keeping medications safe.
Lupkin S; Tribble SJ
Mod Healthc; 2017 Feb; 47(7):10-11. PubMed ID: 30521715
[No Abstract] [Full Text] [Related]
15. Mifepristone--a boom or a bust?
Willke JC
Ann Pharmacother; 2001 Mar; 35(3):376-80. PubMed ID: 11261539
[No Abstract] [Full Text] [Related]
16. FDA considering restricted access to "abortion pill".
Sibbald B
CMAJ; 2000 Sep; 163(5):586. PubMed ID: 11006770
[No Abstract] [Full Text] [Related]
17. Mifepristone approval delayed, supporters look to action by FDA.
Contracept Technol Update; 2000 May; 21(5):53-5. PubMed ID: 12295903
[TBL] [Abstract][Full Text] [Related]
18. ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone.
Mazer-Amirshahi M; Stolbach AI; Ye P
J Med Toxicol; 2023 Oct; 19(4):414-415. PubMed ID: 37548894
[No Abstract] [Full Text] [Related]
19. Profile. For 'father' of abortion drug, vindication at last.
Balter M
Science; 2000 Oct; 290(5489):39. PubMed ID: 11183145
[No Abstract] [Full Text] [Related]
20. Effect of mifepristone approval on research remains to be seen.
Vastag B
J Natl Cancer Inst; 2000 Dec; 92(24):1970-1. PubMed ID: 11121453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
